Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
Portfolio News

Apitope

Apitope is an established leader in discovery and development of antigen-specific immunotherapeutic peptides focused on autoimmune diseases.

http://www.apitope.com

Immunotherapeutics

United Kingdom / Belgium

Investing phase